What to Watch as Pasqal’s SPAC Merger Moves to Close
Pasqal is a neutral-atom quantum computing company going public via merger with Bleichroeder Acquisition Corp. II, the SPAC trading as BBCQ. The deal has already closed, but the setup still matters because the valuation is rich, dilution is heavy, and the company is still proving commercial scale.
Pasqal is a neutral-atom quantum computing company going public via merger with Bleichroeder Acquisition Corp. II, the SPAC trading as BBCQ. The deal has already closed, but the setup still matters because the valuation is rich, dilution is heavy, and the company is still proving commercial scale.
Pasqal is a neutral-atom quantum computing company focused on quantum processing units (QPUs), quantum solutions, and cloud/remote-access offerings. It describes itself as a global leader in neutral-atom quantum computing and says it has 7 quantum computers deployed. The business is built as a full-stack model spanning hardware, software, and cloud, with revenue streams from on-premise QPU sales, remote access/cloud access, and maintenance and upgrades.
The company was founded in 2019 as a spin-off from Institut d’Optique and is headquartered in Palaiseau, France, with regional hubs in Boston, Riyadh, Sherbrooke, and Seoul. Pasqal says it had 10 QPUs in operation and production as of Dec. 2025, 40+ clients/partners, 25+ use cases realized with Orion alpha in 2024–2025, 2 manufacturing facilities fully operational, 275+ employees, and 86 patents. In industry terms, Pasqal is betting that neutral atoms can scale more cleanly than superconducting or trapped-ion approaches, while the broader quantum market remains a long-duration, high-uncertainty race.
The SPAC Deal
Pasqal agreed to merge with Bleichroeder Acquisition Corp. II, which trades under the current SPAC ticker BBCQ. The deal values Pasqal at a $2.0 billion pre-money equity value, with the March 2026 deck showing a pro forma equity value of $2,591.7 million, less cash of $610.7 million, for a pro forma enterprise value of $1,981.0 million. That is a demanding valuation for a company that is still scaling production and commercialization rather than operating as a mature cash generator.
The trust account was about $288.8 million as of Feb. 28, 2026, and the proxy supplement showed trust assets of $289,715,723 as of May 31, 2026. The company’s materials warned that redemptions could reduce the share count and capital available, and the final closing announcement said the business combination completed with approximately $360 million available at closing, implying redemptions and other adjustments took a meaningful bite out of the expected cash. The deal also included $200 million of committed convertible financing, with the 425 describing $312.5 million aggregate principal amount of senior unsecured convertible bonds issued for $250.0 million of subscription price, plus warrants. Sponsor dilution is real: the sponsor owns 9,583,333 founder shares purchased for $25,000, and the capital stack includes 9,583,333 public warrants, 7,750,000 private placement warrants, and investment warrants tied to the convertible financing. The combined company was expected to list on Nasdaq, and the post-closing company is referenced as PSQL. The transaction was announced March 4, 2026, the F-4 was declared effective August 5, 2026, shareholders approved it on August 25, 2026, and Pasqal announced completion on August 27, 2026, so the first trading window was late August 2026.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Pasqal is using the SPAC route to raise capital for commercialization, manufacturing scale-up, and continued development of its neutral-atom platform. The company’s materials point to a broad use of proceeds: expanding production, supporting deployments, and funding the next phase of technical milestones, including larger qubit systems and broader geographic expansion.
The SPAC structure also lets Pasqal market a long-range growth story with projections and a detailed operating roadmap. That matters in quantum, where traditional IPO investors often want more proof of revenue durability and near-term profitability. The sponsor-backed process also gave Pasqal a committed financing package and a faster path to the public markets than a conventional IPO.
Financial Highlights
Pasqal’s deck shows LTM revenue of $80 million+ as of Dec. 2025, with about 1.6x revenue growth since 2024. The company also disclosed $80 million+ in booked and awarded business including grants as of Dec. 2025, which suggests a meaningful pipeline beyond reported revenue. The deck does not provide a full audited income statement in the excerpts reviewed here, so margin and loss detail are limited in the materials provided.
Cash on hand was $157.8 million as of Feb. 28, 2026, and the deck showed $610.7 million of pro forma cash before redemptions, combining existing cash, trust proceeds, and financing. The final closing announcement indicated about $360 million available at closing, so the post-close cash position is lower than the original no-redemption case. Forward-looking projections in the deck include 200+ logical qubits by end of 2029 and impactful quantum advantage demonstrations by end of Q1 2026; those are projections, not results.
Risk Factors
The biggest de-SPAC risk was redemption pressure. The trust started around $289 million, but the final cash available at closing fell to about $360 million after the full capital stack and adjustments, showing how quickly the economics can change once public holders redeem. If redemptions are high, the company gets less cash than the headline structure suggests, and the post-close float can be thinner than expected.
Dilution is also substantial. Founder shares, public warrants, private placement warrants, and convertible-financing warrants all sit on top of the equity. On the business side, Pasqal is still executing on production scale, commercialization, and quantum-advantage milestones in a field where architecture leadership is unsettled. Competition from superconducting and trapped-ion players remains intense, and the deck explicitly notes key-person risk. If the company misses technical or commercial targets, the market can re-rate the story quickly.
Comparable Public Companies
The closest public comps are IonQ (IONQ), D-Wave Quantum (QBTS), Rigetti Computing (RGTI), Quantum Computing Inc. (QUBT), and Arqit Quantum (ARQQ). These names give investors a read on how the market prices early-stage quantum platforms, though Pasqal’s neutral-atom approach is not identical to all of them.
As a group, the quantum comp set has typically traded on revenue growth, technical milestones, and narrative momentum more than current earnings power. That usually means wide valuation swings and elevated sensitivity to execution updates. Pasqal’s own deck leans into that same setup: the market is paying for future platform scale, not near-term profitability.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
The bottom line is that Pasqal’s de-SPAC is now a completed public listing, but the core investor question has shifted from vote risk to execution risk. The deal brought in committed financing and a Nasdaq path, yet the final cash available at closing was below the no-redemption case, and the equity remains heavily diluted by founder shares, warrants, and convertible-linked securities.
Shareholders should watch whether Pasqal can convert its booked business, deployed QPUs, and manufacturing footprint into repeatable commercial revenue. That is why this matters now: the company is public, the ticker has moved to PSQL, and the market will quickly test whether the neutral-atom thesis can justify a $2.0 billion pre-money valuation in a sector where milestones matter more than promises.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Picture
Want the full picture on PSQL?
Everything we track on PSQL in one place — the TickerSpark Score, price charts, key financials, and our latest coverage.
